New York Senate Bill 1196
Session 2023-2024
Requires health insurance policies and medicaid to cover biomarker testing for certain purposes
Became Law
Signed by Governor on Dec 22, 2023
Origin Chamber
Senate
Type
Bill
Bill Number
1196
State
New York
Session
2023-2024
Motion Text
Rules Vote - Version: A
Senate Roll Call Votes
Yes
Yes
Yes
Yes
Summary
Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.
12/22/2023
Senate
APPROVAL MEMO.76
12/22/2023
Senate
SIGNED CHAP.754
12/12/2023
Senate
DELIVERED TO GOVERNOR
06/08/2023
Assembly
RETURNED TO SENATE
06/08/2023
Assembly
PASSED ASSEMBLY
06/08/2023
Assembly
ORDERED TO THIRD READING RULES CAL.679
06/08/2023
Assembly
SUBSTITUTED FOR A1673A
06/05/2023
Assembly
REFERRED TO WAYS AND MEANS
06/05/2023
Senate
DELIVERED TO ASSEMBLY
06/05/2023
Senate
PASSED SENATE
06/05/2023
Senate
ORDERED TO THIRD READING CAL.1451
06/05/2023
Senate
COMMITTEE DISCHARGED AND COMMITTED TO RULES
06/01/2023
Senate
PRINT NUMBER 1196A
06/01/2023
Senate
AMEND AND RECOMMIT TO FINANCE
05/22/2023
Senate
REPORTED AND COMMITTED TO FINANCE
01/10/2023
Senate
REFERRED TO INSURANCE
Sources
NY Legislature
Record Created
Jan 10, 2023 8:35:08 PM
Record Updated
Apr 11, 2024 3:41:04 AM